Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients.
Prieto-Conde MI, Corchete LA, García-Álvarez M, Jiménez C, Medina A, Balanzategui A, Hernández-Ruano M, Maldonado R, Sarasquete ME, Alcoceba M, Puig N, González-Calle V, García-Sanz R, Gutiérrez NC, González-Díaz M, Chillón MC. Prieto-Conde MI, et al. J Mol Diagn. 2020 Jan;22(1):60-71. doi: 10.1016/j.jmoldx.2019.08.002. Epub 2019 Oct 9. J Mol Diagn. 2020. PMID: 31605801 Free article.
Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.
González-Calle V, Dávila J, Escalante F, de Coca AG, Aguilera C, López R, Bárez A, Alonso JM, Hernández R, Hernández JM, de la Fuente P, Puig N, Ocio EM, Gutiérrez NC, García-Sanz R, Mateos MV. González-Calle V, et al. Leukemia. 2016 Oct;30(10):2026-2031. doi: 10.1038/leu.2016.123. Epub 2016 May 2. Leukemia. 2016. PMID: 27133826
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma.
González-Calle V, Cerdá S, Labrador J, Sobejano E, González-Mena B, Aguilera C, Ocio EM, Vidriales MB, Puig N, Gutiérrez NC, García-Sanz R, Alonso JM, López R, Aguilar C, de Coca AG, Hernández R, Hernández JM, Escalante F, Mateos MV. González-Calle V, et al. Haematologica. 2017 May;102(5):922-931. doi: 10.3324/haematol.2016.158345. Epub 2017 Jan 25. Haematologica. 2017. PMID: 28126960 Free PMC article.
Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma.
Navarro-Bailón A, Jiménez C, Alonso-Álvarez S, Alcoceba M, González-Calle V, Chillón MC, García-Álvarez M, Prieto I, Medina A, González M, Caballero MD, Blanco Ó, Díaz LG, García-Sanz R, Sarasquete ME. Navarro-Bailón A, et al. Hematol Oncol. 2019 Apr;37(2):215-218. doi: 10.1002/hon.2570. Epub 2019 Jan 8. Hematol Oncol. 2019. PMID: 30548996 No abstract available.
Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas.
García-Álvarez M, Alonso-Álvarez S, Prieto-Conde I, Jiménez C, Sarasquete ME, Chillón MC, Medina A, Balanzategui A, Maldonado R, Antón A, Puig N, Rodríguez M, Blanco O, Tamayo P, González-Calle V, Martín A, García-Sanz R, González M, Caballero MD, Alcoceba M. García-Álvarez M, et al. Blood Cancer J. 2019 Jun 17;9(7):52. doi: 10.1038/s41408-019-0213-9. Blood Cancer J. 2019. PMID: 31209206 Free PMC article.
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients.
Medina A, Jiménez C, Sarasquete ME, González M, Chillón MC, Balanzategui A, Prieto-Conde I, García-Álvarez M, Puig N, González-Calle V, Alcoceba M, Cuenca I, Barrio S, Escalante F, Gutiérrez NC, Gironella M, Hernández MT, Sureda A, Oriol A, Bladé J, Lahuerta JJ, San Miguel JF, Mateos MV, Martínez-López J, Calasanz MJ, García-Sanz R. Medina A, et al. Blood Cancer J. 2020 Feb 6;10(2):14. doi: 10.1038/s41408-020-0283-8. Blood Cancer J. 2020. PMID: 32029700 Free PMC article.
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma.
Medina A, Puig N, Flores-Montero J, Jimenez C, Sarasquete ME, Garcia-Alvarez M, Prieto-Conde I, Chillon C, Alcoceba M, Gutierrez NC, Oriol A, Rosinol L, Bladè J, Gironella M, Hernandez MT, Gonzalez-Calle V, Cedena MT, Paiva B, San-Miguel JF, Lahuerta JJ, Mateos MV, Martinez-Lopez J, Orfao A, Gonzalez M, Garcia-Sanz R. Medina A, et al. Blood Cancer J. 2020 Oct 30;10(10):108. doi: 10.1038/s41408-020-00377-0. Blood Cancer J. 2020. PMID: 33127891 Free PMC article. Clinical Trial.
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.
Puig N, Corchete-Sánchez LA, Pérez-Morán JJ, Dávila J, Paíno T, de la Rubia J, Oriol A, Martín-Sánchez J, de Arriba F, Bladé J, Blanchard MJ, González-Calle V, García-Sanz R, Paiva B, Lahuerta JJ, San-Miguel JF, Mateos MV, Ocio EM. Puig N, et al. Cancers (Basel). 2020 Dec 3;12(12):3615. doi: 10.3390/cancers12123615. Cancers (Basel). 2020. PMID: 33287189 Free PMC article.
Genetic complexity impacts the clinical outcome of follicular lymphoma patients.
García-Álvarez M, Alonso-Álvarez S, Prieto-Conde I, Jiménez C, Sarasquete ME, Chillón MC, Medina A, Balanzategui A, Maldonado R, Antón A, Rodríguez M, Blanco O, Díaz LG, Tamayo P, Blanco P, Esteban C, González-Calle V, Puig N, Gutiérrez N, Martín A, García-Sanz R, González M, Caballero MD, Alcoceba M. García-Álvarez M, et al. Blood Cancer J. 2021 Jan 11;11(1):11. doi: 10.1038/s41408-020-00395-y. Blood Cancer J. 2021. PMID: 33431798 Free PMC article. No abstract available.
58 results